Fertility Services Global Market Report 2025

Fertility treatment refers to a medical intervention aimed at enhancing the likelihood of conceiving a child, with the objective of increasing the chances of successful childbirth.

Within fertility services, various types are available, including fresh non-donor services, frozen non-donor services, egg and embryo banking, fresh donor services, and frozen donor services. In the context of fresh donor egg in vitro fertilization (IVF) cycles, donor eggs are promptly fertilized with the sperm from the male partner, and the resulting fresh embryos are transferred to the recipient. Any remaining embryos can be preserved for potential use in subsequent frozen embryo transfers. Assisted reproductive technology (ART), in-vitro fertilization, and artificial insemination are among the diverse procedures employed in fertility services, catering to both male and female individuals.

The fertility services market research report is one of a series of new reports from The Business Research Company that provides fertility services market statistics, including fertility services industry global market size, regional shares, competitors with a fertility services market share, detailed fertility services market segments, market trends and opportunities, and any further data you may need to thrive in the fertility services industry. This fertility services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility services market size has grown rapidly in recent years. It will grow from $64.53 billion in 2024 to $74.42 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to high prevalence of pcos (polycystic ovary syndrome), the increasing cases of premature ovarian failure, the rise in male infertility, insurance providers offering coverage for IVF (in vitro fertilization) procedures and the increase in same-sex couples.

The fertility services market size is expected to see rapid growth in the next few years. It will grow to $126.58 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to the rising infertility rate, technological developments in fertility treatment, the growing adoption of fertility services to aid in pregnancy, the increasing government initiatives, the rise in disposable income and the growing trend of late parenthood. Major trends in the forecast period include focus on artificial intelligence in fertility services, technological advancements, preimplantation genetic testing for aneuploidy screening (PGT-a), DNA fragmentation index (DFI), blockchain-based fertility service apps, IoT (internet of things) in in-vitro fertilization services, strategic partnerships and mergers and acquisitions.

The expected rise in infertility rates is set to drive increased demand for fertility services in the forecast period. Various factors related to lifestyle changes, such as obesity, stress or depression, and high alcohol consumption, contribute to the increasing rates of infertility, creating a heightened need for fertility services. As an example, a report from the World Health Organization (WHO) in April 2023 highlighted that millions of individuals worldwide of reproductive age are expected to face challenges with infertility, affecting not only individuals but also families and communities. Globally, an estimated 1 in 6 adults, or approximately 17.5% of the adult population, is projected to grapple with infertility. Thus, the surge in infertility rates is poised to fuel the demand for fertility services in the market.

The anticipated growth of the fertility services market is further driven by the increasing prevalence of Polycystic Ovary Syndrome (PCOS). PCOS, a common hormonal disorder affecting individuals with ovaries during their reproductive years, is on the rise, leading to a higher demand for fertility services such as in-vitro fertilization (IVF) and other assisted reproductive techniques. For example, as of June 2023, the World Health Organization reported that approximately 8-13% of women in their reproductive years are estimated to be affected by PCOS, and a significant portion, as high as 70%, remains undiagnosed globally. Consequently, the growing prevalence of PCOS contributes to the upward trajectory of the fertility services market.

Companies in the fertility services market have observed notable growth in research collaborations and approvals for research funding. Key market players are expected to increase their investment in Research and Development (R&D) to introduce advanced techniques and drugs for fertility treatments. For example, in October 2022, Maven Clinic, a US-based company specializing in telemedicine-based virtual clinics for women's and family health, collaborated with Indira IVF, an India-based infertility specialty clinic chain. The collaboration aimed to provide Maven members in India access to high-quality clinical care, additional benefits, and top-notch virtual family-building care through the Maven platform. Additionally, in February 2021, CooperSurgical, a US-based women's healthcare solutions company, partnered with Virtus Health, an Australia-based fertility services provider. The collaboration focused on digitalization, cryogenics, and reproductive genetics, with initiatives aimed at supporting patients' fertility journeys, including those requiring egg, sperm, or embryo donations.

Major companies in the fertility services market are actively innovating new technologies to optimize In Vitro Fertilization (IVF) procedures and maintain a competitive edge. IVF is a medical procedure that involves combining eggs and sperm outside the body to create embryos, which are then implanted in the uterus to facilitate pregnancy for individuals or couples facing fertility challenges. For example, in October 2022, Alife Health, a US-based medical equipment manufacturing company, launched the Alife Assist platform. This suite of products aims to revolutionize the IVF process by leveraging data-driven insights and artificial intelligence (AI) to support clinical decision-making during crucial IVF stages and streamline fertility clinic operations. The platform includes Stim Assist, Embryo Assist, and Insights, offering comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators, thereby enhancing medication dosing, embryo grading, and real-time performance monitoring to improve the overall patient experience and success rates in IVF procedures.

In November 2023, IVI RMA, a Spain-based company specializing in assisted reproduction technology (ART), acquired the North American operations of Eugin Group. This strategic acquisition strengthens IVI RMA's market leadership in North America and underscores the company's commitment to delivering evidence-based fertility solutions that maximize success for a wide range of patients. Eugin Group is also a Spain-based provider of fertility services.

Major companies operating in the fertility services market include Vitrolife, Merck KGaA, Progyny Inc., Virtus Health, Medicover Group, Apollo Hospitals Enterprise Ltd., Integramed America, Inc., The Johns Hopkins Health System Corp, Care Fertility, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bloom Fertility Center, Center for Advanced Reproductive Medicine and Infertility, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, KL Fertility & Gynecology Centre, LIFE - Lahore Institute of Fertility & Endocrinology, Maria Fertility Hospital, Morula IVF, Nepal International Fertility Centre, Repromed, SAFE Fertility Center, Southend Fertility and IVF, Thomson Medical Pte Ltd, TMC Fertility Centre, Victory A.R.T. Laboratory Phils. Inc, Virtus Health, CHA Fertility Center, United Family Hospital, The New Hope Fertility Center, NOVA IVF Fertility, Baby Joy Fertility and IVF, Fortis La Femme, ART Fertility Clinics, Ferticity Fertility Clinic, Milann Fertility Centre, Fertility First, City Fertility Sydney, Westmead Fertility Centre, Demeter Fertility, Adora Fertility, Rainbow Fertility, Monash IVF Group Limited, Mitra Keluarga Karyasehat Tbk PT, Sarang-i IVF Center, Beyond IVF, Bumrungrad International Hospital, Superior A.R.T, King's Fertility, Manchester Fertility, St Roch IVF Center, Clinique De La Muette, Institut Marques, Hopital Cochin, iTrust Fertility, Apricity, Agora Clinic, TFP Fertility, Apryl, CCRM Fertility Clinic, ORIGIO, Maven Clinic, Bayonne Centre, Biomedival, Grand Paris Fertility Centre, Ava-Peter Clinic, IVF Russia (The International Centre Of The Reproductive Medicines), Next Generation Clinic, Scandinavia AVA-Peter, Nova Vita Clinic, INVICTA Fertility Clinics, Gyncentrum Fertility Clinic, Md Medical Group, Invo Bioscience, New Hope Fertility Center, Carolinas Fertility Institute, Newlife Fertility Centre, Dallas Fort Worth Fertility Associates, Overlake Reproductive Health, Fertility Center Of Las Vegas, Weill Cornell Medicine - Center For Reproductive Medicine, UCSF Center For Reproductive Health, Brigham And Women's Hospital Center For Infertility And Reproductive Surgery, Columbia University Fertility Center, Duke Fertility Center, Advanced Fertility Center Of Texas, Cleveland Clinic Fertility Center, NYU Langone Fertility Center, Mayo Clinic Assisted Reproductive Technologies Rochester, Massachusetts General Hospital Fertility Center, IVF Canada, Bio Fertility Center, The Mexican Institute For Higher Reproductive Technology (Inmater), Select IVF, Fertility Patagonia, In Vitro Buenos Aires, Halitus Instituto Medico, Pregna Medicina Reproductiva, IVF Panama Centro De Reproduccion Punta Pacifica, Colombian Center For Fertility, Sterility, Carrot Fertility, Oya Care, Kitazato, Dubai Fertility Center, Fakih IVF Fertility Center, Orchid Fertility, Bourn Hall Fertility Clinic, Alboshra IVF Center, George's Memorial Medical Centre, Nordica Fertility Centre, The Olive Branch Clinic, St. Ives Specialist Hospital, Bridge Clinic Fertility Centre, Cairo Fertility Centre, Queens Fertility Centre, BPE Partners, Cleopatra Hospitals Group

Western Europe was the largest region in the fertility services market in 2024. North America was the second largest region in global fertility services market share. The regions covered in the fertility services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The fertility services market includes revenues earned by entities by providing artificial insemination, and intrauterine insemination. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fertility Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fertility services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fertility services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fertility services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Procedure: Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination
• 2) By Service: Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor
• 3) By Application: Male, Female
• Subsegments:
• 1) By Assisted Reproductive Technology (ART): Intracytoplasmic Sperm Injection (ICSI); Frozen Embryo Transfer (FET); Donor Egg And Sperm Programs
• 2) By In-Vitro Fertilization (IVF): Conventional IVF; Mini IVF (Mild Stimulation IVF); Natural Cycle IVF
• 3) By Artificial Insemination: Intrauterine Insemination (IUI); Intracervical Insemination (ICI); Intratubal Insemination (ITI)
• Companies Mentioned: Vitrolife; Merck KGaA; Progyny Inc.; Virtus Health; Medicover Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.